Sunday 18 October 2026 Export CCCC’s income statement to Excel — free account

C4 Therapeutics, Inc.

C4 Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.9 million, up 1.02% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS grew 51.4% and free cash flow grew 86.8%, each against the same quarter a year earlier.

2.77 0.01 −0.36%

Follow CCCC

Alert me

Market cap: $342.0M
P/E: 0.0×
Fwd P/E: −4.1×
Dividend yield: —
F-score: 4/9
Altman Z: −2.16
Beneish M: −2.61
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	17.42	9.51	4.40	5.35
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(387.77)	(11.07)	(7.15)	(5.16)
P/B ratio Full definition →	2.47	1.42	0.62	1.04
Price to Tangible BV Full definition →	2.47	1.42	0.62	1.04
EV/Sales Full definition →	10.72	3.29	(1.98)	(0.39)
EV/EBITDA Full definition →	0.00	0.00	0.61	0.09
EV/Operating CF Full definition →	(4.43)	(1.20)	0.72	0.13
EV/FCF Full definition →	(4.40)	(1.20)	0.72	0.12
Quick Ratio Full definition →	5.29	8.75	7.60	5.52
Current Ratio Full definition →	5.45	9.00	7.81	5.76
Net Debt/EBITDA Full definition →	9.64	8.28	10.54	5.57
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.11	0.11	0.10	0.09
Operating CF/Net income Full definition →	0.07	1.19	1.08	0.97
Capex/Depreciation Full definition →	(0.35)	0.09	0.03	7.47
Interest Coverage Full definition →	9.48	10.46	4.61	—
Research and Development Expense of Revenue Full definition →	368.48%	399.97%	226.78%	231.42%
Selling, General and Administrative Expense of Revenue Full definition →	129.39%	151.67%	83.32%	79.43%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	45.72%	43.42%	36.37%	40.90%
Graham Net Nets Full definition →	0.25	0.45	0.98	0.59
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(21.41%)	(45.25%)	(71.20%)	(75.23%)
Free Cash Flow Yield Full definition →	(13.99%)	(28.96%)	(62.72%)	(59.01%)
Revenue per Share Full definition →	0.05	0.05	0.13	0.15
Operating CF per Share Full definition →	(0.01)	(0.24)	(0.27)	(0.43)
Capex per Share Full definition →	0.00	0.00	0.00	(0.01)
Free Cash Flow per Share Full definition →	(0.01)	(0.24)	(0.27)	(0.44)
Cash per Share Full definition →	1.94	1.87	3.00	2.64
Shareholders Equity per Share Full definition →	1.89	1.86	3.10	2.13
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.89	1.86	3.10	2.13
Free Cash Flow Full definition →	(1.61)	(30.01)	(22.16)	(31.62)
Working Capital Full definition →	214.66	218.12	225.08	170.92
Capital Expenditures Full definition →	(0.04)	(0.06)	(0.01)	(0.41)
Net Current Asset Value Full definition →	150.76	150.76	155.62	95.78
EV/EBIT Full definition →	0.00	0.00	0.62	0.09
Capex to Sales Full definition →	0.01	0.01	0.00	0.04
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	1.75	5.46	2.75	8.44
Average Payables Full definition →	1.67	0.73	1.09	1.42
Average Assets Full definition →	327.97	324.19	354.34	320.77
Average Common Equity Full definition →	210.66	214.69	236.29	198.53

Fold the line items

Columns are period end dates

Stockrow Weekly